CTI BioPharma Corp. (CTIC): Price and Financial Metrics


CTI BioPharma Corp. (CTIC)

Today's Latest Price: $1.25 USD

0.07 (-5.30%)

Updated Feb 14 12:00am

Add CTIC to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 339 in Biotech

See all "A" rated Strong Buy stocks

CTIC Stock Summary

  • With a year-over-year growth in debt of -27.26%, Cti Biopharma Corp's debt growth rate surpasses merely 10.91% of about US stocks.
  • Revenue growth over the past 12 months for Cti Biopharma Corp comes in at 45.19%, a number that bests 88.42% of the US stocks we're tracking.
  • In terms of volatility of its share price, CTIC is more volatile than 88.02% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Cti Biopharma Corp, a group of peers worth examining would be QUIK, QTNT, RMBS, APVO, and DNN.
  • Visit CTIC's SEC page to see the company's official filings. To visit the company's web site, go to www.ctibiopharma.com.
CTIC Daily Price Range
CTIC 52-Week Price Range

CTIC Stock Price Chart More Charts


CTIC Price/Volume Stats

Current price $1.25 52-week high $1.93
Prev. close $1.32 52-week low $0.63
Day low $1.25 Volume 193,300
Day high $1.34 Avg. volume 273,139
50-day MA $1.34 Dividend yield N/A
200-day MA $0.94 Market Cap 72.47M

CTI BioPharma Corp. (CTIC) Company Bio


CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. The company was founded in 1991 and is based in Seattle, Washington.


CTIC Latest News Stream


Event/TimeNews Detail
Loading, please wait...

CTIC Latest Social Stream


Loading social stream, please wait...

View Full CTIC Social Stream

CTIC Price Returns

1-mo -9.42%
3-mo 73.27%
6-mo 82.88%
1-year 31.58%
3-year -73.63%
5-year -94.66%
YTD -20.89%
2019 116.44%
2018 -72.76%
2017 -34.63%
2016 -66.67%
2015 -47.88%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6617 seconds.